How do I perform intrauterine balloon tamponade for postpartum hemorrhage due to uterine atony after failure of uterotonics (oxytocin, methylergonovine, carboprost, misoprostol) and tranexamic acid in a hemodynamically unstable postpartum patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Perform Intrauterine Balloon Tamponade for Postpartum Hemorrhage

Intrauterine balloon tamponade should be implemented immediately after failure of uterotonics and tranexamic acid, before proceeding to interventional radiology or surgical interventions, as it achieves hemostasis in 90% of properly placed cases and 100% of uterine atony cases. 1, 2

Pre-Procedure Preparation

  • Ensure large-bore IV access is established with ongoing aggressive crystalloid resuscitation 3
  • Activate massive transfusion protocol if blood loss exceeds 1,500 mL, transfusing packed RBCs, FFP, and platelets in 1:1:1 ratio 4
  • Administer second dose of tranexamic acid 1g IV if bleeding continues after 30 minutes or restarts within 24 hours of first dose 1, 4
  • Continue uterine massage and bimanual compression during preparation 4
  • Obtain informed consent if patient is stable enough; in emergencies, proceed under implied consent 2

Device Selection and Preparation

  • Use commercially available intrauterine balloon catheters (Bakri balloon, BT-Cath, or similar devices) designed specifically for postpartum hemorrhage 5
  • Prepare sterile water or normal saline for balloon inflation (typically 300-500 mL capacity) 2
  • Have additional gauze available; consider wrapping balloon in gauze impregnated with tranexamic acid for refractory cases, as this combines mechanical compression with topical antifibrinolytic effect 6

Placement Technique

For Vaginal Delivery:

  • Perform thorough pelvic examination to rule out cervical or vaginal lacerations as contributing factors 5
  • Insert the deflated balloon catheter transcervically into the uterine cavity, advancing it to the fundus 2
  • Inflate the balloon with sterile water incrementally (start with 250-300 mL, up to 500 mL) until vaginal bleeding stops 2
  • Apply gentle traction on the catheter to ensure it is seated against the lower uterine segment 2
  • Pack the vagina with gauze to prevent balloon expulsion through the cervix 2

For Cesarean Delivery:

  • Place the deflated balloon directly into the uterine cavity through the hysterotomy before closure 5
  • Inflate the balloon to 300-500 mL under direct visualization 2
  • Close the hysterotomy around the catheter shaft 5
  • Bring the catheter out through the cervix and vagina 2

Confirmation of Proper Placement

  • Verify cessation of vaginal bleeding after inflation—this is the primary indicator of successful placement 2
  • Monitor drainage through the catheter port; minimal or no drainage indicates effective tamponade 2
  • Critical warning: Severe stabbing pain despite analgesia, refractory hemorrhage, or hemodynamic instability after placement may indicate iatrogenic uterine rupture and requires immediate removal and exploratory laparotomy 7

Post-Placement Management

  • Maintain continuous hemodynamic monitoring for at least 24 hours due to significant fluid shifts 1, 4
  • Continue oxytocin infusion (up to 80 IU for high-risk cases shows 47% reduction in hemorrhage compared to 10 IU) 1
  • Keep balloon inflated for 12-24 hours if bleeding is controlled 2
  • Monitor for complications: infection, uterine rupture, balloon migration 7
  • Administer prophylactic antibiotics and re-dose if blood loss exceeded 1,500 mL 4

Balloon Removal

  • Deflate and remove the balloon gradually after 12-24 hours if no bleeding recurs 2
  • Remove vaginal packing simultaneously 2
  • Monitor closely for 2-4 hours after removal for recurrent bleeding 2
  • If bleeding recurs, reinflate the balloon or proceed to surgical intervention 2

When Balloon Tamponade Fails

  • Success rate is 90% when properly placed overall, but only 80% for retained placenta and may fail in placenta percreta 2
  • If bleeding continues despite proper placement, proceed immediately to: 5, 1
    • Bilateral uterine artery ligation
    • B-Lynch compression sutures
    • Interventional radiology for arterial embolization (requires hemodynamic stability for transfer)
    • Hysterectomy as last resort

Critical Pitfalls to Avoid

  • Do not delay placement—balloon tamponade is a first-line conservative measure after uterotonic failure, not a last resort 1
  • Technical failure occurs in approximately 13% of cases (3/23 in one series); ensure adequate training before attempting 2
  • Do not ignore severe pain—this may indicate uterine rupture requiring immediate removal and laparotomy 7
  • Maintain normothermia—warm all infusion solutions and blood products, as clotting factors function poorly at lower temperatures 4

References

Guideline

Management of Postpartum Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Emergency Management of Intrauterine Miscarriage with Hemodynamic Instability

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Postpartum Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the most appropriate initial step in managing a postpartum hemorrhage (PPH) in a patient with a soft uterus and ongoing bleeding despite uterine massage, with symptoms of tachycardia and normal blood pressure, following a vaginal delivery with oxytocin (Pitocin) infusion?
What is the diagnosis for a 39-year-old primigravida (first pregnancy) at 38 weeks gestation with a history of hypertension treated with nifedipine (calcium channel blocker) and asthma treated with albuterol (beta-2 adrenergic receptor agonist), who develops postpartum hemorrhage (PPH) with a soft uterus after a forceps-assisted vaginal delivery and manual placental extraction?
What is the best next step in managing a postpartum woman with severe vaginal bleeding, uterine atony, and tachycardia, unresponsive to uterine massage and high-dose oxytocin?
What is the most appropriate next step in managing a patient with a densely adherent placenta to the anterior uterine wall after a repeat cesarean delivery (C-section)?
What are the guidelines for managing postpartum hemorrhage (PPH) due to delivery bleeding?
What is the appropriate dose and treatment duration of saroglitazar for an adult patient with non‑alcoholic fatty liver disease (NAFLD) or non‑alcoholic steatohepatitis (NASH) who does not have decompensated cirrhosis?
What is the appropriate management for a post‑viral cough?
What is the appropriate management for an asymptomatic 30‑year‑old male with a fasting triglyceride level of 2.20 mmol/L?
When is ipratropium bromide contraindicated (e.g., hypersensitivity to anticholinergics, narrow‑angle glaucoma, severe urinary retention or obstructive benign prostatic hyperplasia, gastrointestinal or urinary tract obstruction, infants younger than 2 years)?
What is the recommended empiric and definitive antibiotic regimen and treatment duration for Morganella morganii infection in a hospitalized, immunocompromised patient with an indwelling catheter, recent abdominal surgery, or prolonged antibiotic exposure?
How should a 32-year-old woman with a fasting total cholesterol of 5.2 mmol/L be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.